Publikasi

Clinically Actionable Insights: A Q&A with Dr. Luciano ...

In 2021, Susan Bobulsky sat down with Dr. Luciano Costa to learn about the initi...

Immune Medicine in Action: How Adaptive Immunosequencin...

Adaptive Immunosequencing provided critical insight into the T-cell response eli...

When the Doctor Becomes the Caregiver

In honor of Multiple Myeloma Awareness Month, we sat down with Dr. Hamza Hashmi,...

Decoding Public T-cell Signatures of Disease with Tens ...

In the ever-evolving field of immunology, the study of T-cell responses to vario...

PACE panel urges incentives for exciting new GTT drugs

Luke Rosen had hoped a new treatment would slow the progression of his daughter’...

Ahead of BIO IP Conference, research highlights why bio...

Venture capital funding for life sciences startups plummeted after legal changes...

PACE: Downstream effects of IRA on patients

Three years after the passage of the Inflation Reduction Act (IRA), patient advo...

BIO on the American Road: Indiana, a production powerho...

At a time when the biopharma industry is seeking to increase U.S. manufacturing,...

BIO Coffee Chat: Guiding patients through Part D open e...

Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 and run...

Oncologist warns PBM step therapy has ‘crossed a danger...

Cancer patients are suffering serious health consequences because step therapy p...

National Family Caregivers Month: Recognizing 63 millio...

November is National Family Caregivers Month, and to mark the occasion, Bio.News...

Job titles of the future: AI embryologist

Embryologists are the scientists behind the scenes of in vitro fertilization who...

New noninvasive endometriosis tests are on the rise

Shantana Hazel often thought her insides might fall out during menstruation. It ...

Cloning isn’t just for celebrity pets like Tom Brady’s dog

This week, we heard that Tom Brady had his dog cloned. The former quarterback re...

Here’s the latest company planning for gene-edited babies

A West Coast biotech entrepreneur says he’s secured $30 million to form a public...

Here’s why we don’t have a cold vaccine. Yet.

For those of us in the Northern Hemisphere, it’s the season of the sniffles. As ...